MESA VERDE VENTURE PARTNERS — Full Portfolio

Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.

BiotechDigital HealthHealthtechMedical DevicesVista, US

TDThierry Dervieux(Executive Officer)inWendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)John Aballi(President & CEO)inJBJeffrey Black(Chief Financial Officer and Corporate Secretary)in

BoardJLJames L.L. Tullis(Director)in

Co-investorsCOCottonwood Technology FundEPEPIC VENTURESH.H.I.G. CapitalH.H.I.G. HealthBridge PartnersSUSun Mountain CapitalTUTullis Health Investors

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

CPChris Peetz(Co-founder & Chief Executive Officer)inEBEric Bjerkholt(Executive Officer)inPRPeter Radovich(Executive Officer)in

BoardPHPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Co-investorsCHChiesi VenturesFRFrazier Life SciencesLOLongitude CapitalNENew Enterprise Associates (NEA)PAPappas CapitalRIRiverVest Venture Partners+4 more

Alastin is a scientific skincare brand offering clinically formulated products, including treatments for skin discoloration, hydrating and soothing formulations, and tinted sun protection, built around its proprietary TriHex Technology.

BiotechConsumerDirect to ConsumerWellness & FitnessDel Mar, US

DGDiane GoostreeinScott L. Glenn(Executive Officer, Director)

BoardTed Schwarz(Director)Maryanne K. Sorge(Director)Mark G. Rubin(Director)Cam Garner(Director)

Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology.

BiotechDigital HealthMedical DevicesSan Diego, US

Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)

Co-investorsBIBioBrit

Immix Biopharma is a clinical-stage biopharmaceutical company developing NXC-201, a BCMA-targeted CAR-T cell therapy for relapsed/refractory AL amyloidosis and other plasma cell-driven immune diseases.

BiotechHealthtechLos Angeles, US

Gabriel Morris(Chief Financial Officer)inIRIlya Rachman(Founder & Chief Executive Officer)inDavid Marks(Chief Medical Officer)

BoardCarey Ng(Director)Magda Marquet(Director)Jane Buchan(Director)

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.

BiotechDeep TechHealthtechSeattle, US

MSMatthew Scholz(Founder)inSASean Ainsworth(Chief Executive Officer)inRSRobert Sikorski(Chief Medical Officer)RHRob Hayes(Chief Scientific Officer)inSMScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in

Co-investorsBIBioRock VenturesBOBoston Harbor AngelsBRBreakout VenturesEQEQx FundINInvariantes FundMIMichigan Capital Network+6 more

Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.

Allen Chao(Founder)

Co-investorsAIAisling CapitalARARCH Venture PartnersPRProspect Venture PartnersSCSchooner CapitalALALTITUDE LIFE SCIENCE VENTURESFOFoley Ventures+2 more

Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications.

BiotechDigital HealthHealthtechMedical DevicesSalt Lake City, US

Gayland Moffat(Executive Officer)Michael S. Paul(Executive Officer, Director)

BoardMichael Fitzgerald(Director)Fred A. Middleton(Director)Mary C. Tanner(Director)Michael Walsh(Director)

Co-investorsMOMountain Group CapitalHEHealthQuest Capital

Merck is a science-led pharmaceutical company that develops medicines and vaccines for patients globally.

BiotechHealthtechMedical Devices

RDRob Davisin

Co-investorsSASanderling Ventures

BiotechDublin 1

Jennifer Schranz(Executive Officer)Axel Bolte(Director)Gary Sender(Executive Officer)Theodore Schroeder(Executive Officer, Director)Robert Crotty(Executive Officer)Colin Broom(Director)

Co-investorsAIAisling CapitalECEcoR1 CapitalFRFrazier Life SciencesLOLongitude CapitalNONovartis Venture Fund

Clinical-stage oncology company developing cancer treatments

BiotechDel Mar, US

Dana McGowan(Treasurer and Secretary)Karen Lundgren(Vice President and Chief Scientific Officer)LGLauren G. Otsuki(Chief Business Officer)inJames Freddo(Chief Medical Officer)James B. Breitmeyer, M.D., Ph.D.(President and Chief Executive Officer)

BoardDavid F. Hale(Director)

Co-investorsVEVedanta Capital

SMPA (Sunovion) is a pharmaceutical company focused on drug discovery, development, and commercialization aimed at bringing novel medicines to patients with unmet health needs.

BiotechHealthtech

Supernus is a pharmaceutical company that develops and markets products in the biosciences and pharmaceutical industry.

BiotechHealthtechRockville, US

Jack A. Khattar(Executive Officer, Director)Padmanabh P. Bhatt, Ph.D.(Executive Officer)inPaolo Baroldi, M.D., Ph.D.(Executive Officer)Tami T. Martin, R.N., Esq.(Executive Officer)Russell P. Wilson(Executive Officer)in

BoardMichael B. Sheffery, Ph.D.(Director)

Co-investorsNENew Enterprise Associates (NEA)